• Title/Summary/Keyword: Sungkyunkwan

Search Result 14,627, Processing Time 0.041 seconds

The first private-hospital based proton therapy center in Korea; status of the Proton Therapy Center at Samsung Medical Center

  • Chung, Kwangzoo;Han, Youngyih;Kim, Jinsung;Ahn, Sung Hwan;Ju, Sang Gyu;Jung, Sang Hoon;Chung, Yoonsun;Cho, Sungkoo;Jo, Kwanghyun;Shin, Eun Hyuk;Hong, Chae-Seon;Shin, Jung Suk;Park, Seyjoon;Kim, Dae-Hyun;Kim, Hye Young;Lee, Boram;Shibagaki, Gantaro;Nonaka, Hideki;Sasai, Kenzo;Koyabu, Yukio;Choi, Changhoon;Huh, Seung Jae;Ahn, Yong Chan;Pyo, Hong Ryull;Lim, Do Hoon;Park, Hee Chul;Park, Won;Oh, Dong Ryul;Noh, Jae Myung;Yu, Jeong Il;Song, Sanghyuk;Lee, Ji Eun;Lee, Bomi;Choi, Doo Ho
    • Radiation Oncology Journal
    • /
    • v.33 no.4
    • /
    • pp.337-343
    • /
    • 2015
  • Purpose: The purpose of this report is to describe the proton therapy system at Samsung Medical Center (SMC-PTS) including the proton beam generator, irradiation system, patient positioning system, patient position verification system, respiratory gating system, and operating and safety control system, and review the current status of the SMC-PTS. Materials and Methods: The SMC-PTS has a cyclotron (230 MeV) and two treatment rooms: one treatment room is equipped with a multi-purpose nozzle and the other treatment room is equipped with a dedicated pencil beam scanning nozzle. The proton beam generator including the cyclotron and the energy selection system can lower the energy of protons down to 70 MeV from the maximum 230 MeV. Results: The multi-purpose nozzle can deliver both wobbling proton beam and active scanning proton beam, and a multi-leaf collimator has been installed in the downstream of the nozzle. The dedicated scanning nozzle can deliver active scanning proton beam with a helium gas filled pipe minimizing unnecessary interactions with the air in the beam path. The equipment was provided by Sumitomo Heavy Industries Ltd., RayStation from RaySearch Laboratories AB is the selected treatment planning system, and data management will be handled by the MOSAIQ system from Elekta AB. Conclusion: The SMC-PTS located in Seoul, Korea, is scheduled to begin treating cancer patients in 2015.

Development of Personal Robot Platform : Designed Approach for Modularization

  • Roh, Se-gon;S. M Baek;Lee, D. H;Park, K. H;T. K Moon;S. W Ryew;T. Y Kuc;Kim, H. S;Lee, H. G H
    • 제어로봇시스템학회:학술대회논문집
    • /
    • 2002.10a
    • /
    • pp.117.3-117
    • /
    • 2002
  • In this paper a new framework is presented for developing the personal robot being used in home environments. We mainly focus on the system engineering technology such as the modularization and standardization. Effective ways for interfacing among modules are addressed regarding compatibility in hardware and software, and as a result a personal robot platform named DHR I is built. The robot is composed of five modules such as brain, mobile, sensor, vision, and user interface modules. Each module can be easily plugged in the system in a mechanical as well as electrical sense by sharing the communication protocol with IEEE1394 FireWire. &n...

  • PDF

Pharmacokinetic Scaling of SJ-8029. a Novel Anticancer Agent Possessing Microtubule and Topoisomerase Inhibiting Activities. by Species-Invariant Time Methods

  • Kim, Dong-Hwan;Shin, Beom-Soo;Cho, Chang-Youn;Park, Si-Koung;Chung, Sung-Gan;Cho, Eui-Hwan;Lee, Sun-Hwan;Joo, Jeong-Ho;Kwon, Ho-Suk
    • Proceedings of the PSK Conference
    • /
    • 2002.10a
    • /
    • pp.422.1-422.1
    • /
    • 2002
  • This study examined the pharmacokinetic disposition of SJ-8029. a novel anticancer agent possessing microtubule and topoisomerase inhibiting activities. in mice. rats. rabbits and dogs after i.v. administration. The serum concentration-time curves of SJ-8029 were best described by tri-exponential equations in all these animal species. The mean CI. $V_{ss}$ and $t_{1/2}$ were 0.3 L/h. 0.1 Land 63.2 min in mice. 1.5 L/h. 1.6 Land 247.7 min in rats. 13.8 L/h. 39.6 Land 245.9 min in rabbits. and 29.2 L/h. 44.6 Land 117.4 min in dogs. respectively. (omitted)

  • PDF